Sacubitril/Valsartan Reduces mPAP, Improves Functional Capacity in HFpEF-PH - AJMC.com Managed Markets Network

Sacubitril/valsartan reduced mean pulmonary artery pressure (mPAP) and improved lung congestion, functional capacity, and quality of life in a subset of patients with heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF-PH) using a…

A study published in ESC Heart Failure found that sacubitril/valsartan (Sac/Val) improved the mean pulmonary artery pressure (mPAP) of patients with heart failure with preserved ejection fraction and… [+4165 chars]

full article...